Raia Drogasil (BSP:RADL3) Debt-to-Equity : 1.19 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Debt-to-Equity?

Raia Drogasil's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was R$1,463 Mil. Raia Drogasil's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was R$5,604 Mil. Raia Drogasil's Total Stockholders Equity for the quarter that ended in Dec. 2023 was R$5,956 Mil. Raia Drogasil's debt to equity for the quarter that ended in Dec. 2023 was 1.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Raia Drogasil's Debt-to-Equity or its related term are showing as below:

BSP:RADL3' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.11 Med: 0.66 Max: 1.19
Current: 1.19

During the past 13 years, the highest Debt-to-Equity Ratio of Raia Drogasil was 1.19. The lowest was 0.11. And the median was 0.66.

BSP:RADL3's Debt-to-Equity is ranked worse than
75.36% of 552 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs BSP:RADL3: 1.19

Raia Drogasil Debt-to-Equity Historical Data

The historical data trend for Raia Drogasil's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Debt-to-Equity Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.07

1.17

1.11

1.13

1.19

Raia Drogasil Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															1.13	1.10	1.14	1.23	1.19

Competitive Comparison of Raia Drogasil's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Debt-to-Equity falls into.

Raia Drogasil Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Raia Drogasil's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1463.068	+	5604.396)	/	5956.001
	=	1.19

Raia Drogasil's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1463.068	+	5604.396)	/	5956.001
	=	1.19

Raia Drogasil (BSP:RADL3) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Raia Drogasil Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (BSP:RADL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

RADLY:USA

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines